The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines

Journal of Infectious Diseases

Volumn 182, Issue 1, 2000, Pages 200-205

  Klein, Marina B ^a,c,e   Hu, Shuxian ^b   Chao, Chun C ^b,d   Goodman, Jesse L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d HoChi Universal Love Culture Educ ^*  (Taiwan)

^e ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW SUPPRESSION; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; CYTOPENIA; EHRLICHIOSIS; GRANULOCYTE; HEMATOPOIESIS; HOST RESISTANCE; HUMAN; HUMAN CELL; INFECTION RESISTANCE; PRIORITY JOURNAL;

BONE MARROW CELLS; CHEMOKINE CCL2; CHEMOKINES; CYTOKINES; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; ENDOTOXINS; GRANULOCYTES; HEAT; HL-60 CELLS; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-8; MACROPHAGE INFLAMMATORY PROTEIN-1;

EID: 0033914787     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315641     Document Type: Article

References (23)

1. 1. Adams DH, Lloyd AR. Chemokines: leukocyte recruitment and activation cytokines. Lancet 1997; 349:490-5.
2. 2. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:436-45.
3. 3. Cook DN, Beck MA, Coffman TM, et al. Requirement of MIP-1α for an inflammatory response to viral infection. Science 1995; 269:1583-5.
4. 4. Cocchi F, De Vico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1α, and MTP-1 B as the major HIV-suppressive factors produced by CD8 T cells. Science 1995; 270:1811-2.
5. 5. Graham GJ, Wright EG, Hewick R, et al. Identification and characterization of an inhibitor of the haemopoietic stem cell proliferation. Nature 1990; 344:442-3.
6. 6. Broxmeyer HE, Sherry B, Lu L, et al. Enhancing and suppressing effects of recombinant murine macrophage inflammation proteins on colony formation in vitro by bone marrow myeloid cells. Blood 1990; 76:1110-6.
7. 7. Broxmeyer HE, Sherry B, Cooper S, et al. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. J Immunol 1993; 150: 3448-58.
8. 8. Bakken JS, Kreuth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996; 275: 199-205.
9. 9. Chen S-M, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytic ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994; 23:589-95.
10. 10. Klein MB, Miller JS, Nelson CN, Goodman JL. Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis. J Infect Dis 1997; 176:1405-9.
11. 11. Goodman JL, Nelson CN, Vitale B, et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996; 334:209-15.
12. 12. Klein MB, Hayes SF, Goodman JL. Monocytic differentiation inhibits and granulocytic differentiation potentiates infection by the agent of human granulocytic ehrlichiosis. Infect Immun 1998; 66:3410-5.
13. 13. Peterson PK, Hu S, Salak-Johnson J, Molitor TW, Chao CC. Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J Infect Dis 1997; 175:478-81.
14. 14. Sprenger H, Krause A, Kaufmann A, et al. Borrelia burgdorferi induces chemokines in human monocytes. Infect Immun 1997; 65:4384-8.
15. 15. Burgmann H, Hollenstein U, Wenisch W, Thalhammer F, Looareeuwan S, Graninger W. Serum Concentrations of MIP-1α and IL-8 in patients suffering from acute plasmodium falciparum malaria. Clin Immunol Immunopathol 1995; 76:32-36.
16. 16. Baggiolini M, Dewald D, Moser B. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol 1994; 55:97-179.
17. 17. Lin Y, Zhang M, Barnes PF. Chemokine production by a human alveolar epithelial cells line in response to mycobacterium tuberculosis. Infect Immun 1998; 66:1121-6.
18. 18. Dasch GA, Weiss E, Willaims JC. Antigenic properties of the ehrlichiae and other rickettsiae. In: Williams JC, Kakoma I, eds. Ehrlichiosis: a vector borne illness of animals and humans. Boston: Kluwer Academic, 1990: 32-58.
19. 19. Wooten RM, Modur VR, McIntyre TM, Weis, JJ. Borrelia burgdorferi outer membrane protein A induces nuclear translocation of the nuclear factor-κb and inflammatory activation in human endothelial cells. J Immunol 1996; 157:4584-90.
20. 20. McDonald PP, Bald A, Cassatella MA. Activation of the NF-κb pathway by inflammatory stimuli in human neutrophils. Blood 1997; 89:3421-33.
21. 21. Goodman JL, Nelson CM, Klein MB, Hayes SF, Weston BW. Leukocyte infection by the granulocytic ehrlichiosis agent is linked to expression of a selectin ligand. J Clin Invest 1999; 103:407-12.
22. 22. Herron MJ, Nelson CM, Larson J, Snapp KR, Goodman JL. Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the p-selectin ligand, PSGL-1. Science 2000; 288:1653-6.
23. 23. Weyrich AS, McIntyre TM, McEver RP, Zimernan GA. Monocyte tethering by p-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-α secretion, signal integration and NF-κb translocation. J Clin Invest 1995; 95:2297-303.